Clinical Trials Sponsored by Circa Scientific

Total 1983 results

University of California, San Diego
Circa Scientific

Completed

Evaluation of the CIRCA Monitoring System in Prevention of Esophageal Lesions Following RFCA (CIRCA-EGD)

Atrial Fibrillation

United States
University of Sao Paulo General Hospital
Circa Scientific

Completed

Randomized Study on the Effect of Oesophageal Temperature on the Incidence of Esophageal Lesions After AF Ablation

Atrial Fibrillation | Cardiac Arrhythmias | Esophageal Ulcer

Brazil
Fundació Eurecat
Circe, S.L.

Not yet recruiting

Oral Bioavailability of a New Formulation of Pterostilbene Cocrystal in Comparison With Its Free Form (BIOPTERO2) (BIOPTERO2)

Biological Availability

Spain
Fundació Eurecat
Circe, S.L.

Completed

Oral Bioavailability of Pterostilbene Cocrystal Compared to Its Free Form (BIOPTERO) (BIOPTERO)

Biological Availability

Spain
Ayca Solt Kirca

Completed

Stria Gravidarum and Olive Oil for Pregnancy Women

Pregnancy Related | Striae Gravidarum

Turkey
David Garcia Cinca

Unknown

Progression of Damage in Ulcerative Colitis (PRODUC)

Ulcerative Colitis

Spain
Fraser, Cira, Ph.D., RN, ACNS-BC

Unknown

A Prospective Study of Spasticity in Individuals With Multiple Sclerosis

Spasticity

United States
Jenscare Scientific

Not yet recruiting

A Prospective, Multicenter Study to Evaluate the JensClip Transcatheter Valve Repair System

Mitral Valve Regurgitation | Degenerative Mitral Valve Disease
Semler Scientific

Completed

Measuring Cardiovascular Performance and Blood Flow Using Common But Never Compared Methods

D012039 | D001775

United States
Jenscare Scientific

Recruiting

A Study to Evaluate the Safety and Performance of LuX-Valve Plus System for Tricuspid Replacement

Tricuspid Regurgitation

France
Hero Scientific

Recruiting

Detection of Group A β-Hemolytic Streptococci in Oral Samples

Group A β-Hemolytic Streptococci

Israel
Jenscare Scientific

Enrolling by invitation

The JensClip Transcatheter Valve Repair System for Treating Functional Mitral Regurgitation

Functional Mitral Regurgitation

China
Novus Scientific

Completed

Safety and Performance Study of TIGR Matrix Surgical Mesh in Inguinal Hernia Repair

Inguinal Hernia

Sweden
MD Scientific

Terminated

Evaluation of Sodium Bicarbonate to Reduce the Incidence of Contrast Induced Chronic Kidney Injury in Patients With Kidney Disease (BOSS)

Contrast Induced Kidney Injury.

United States
Boston Scientific Corporation

Not yet recruiting

VITALYST Early Feasibility Study in High-Risk PCI Patients (VITALYST EFS) (VITALYST EFS)

Heart Disease, Coronary | High-risk Percutaneous Coronary Intervention

United States, Sweden
Boston Scientific Corporation

Recruiting

MANTIS Endoscopic Clipping Study

Endoscopy | Hemostasis | Perforation Colon | Feeding Tube Complication

United States, India, Hong Kong, Canada, Japan, China
Boston Scientific Corporation

Recruiting

Watchman FLX Pro CT Pilot Study

Non-valvular Atrial Fibrillation (AF)

Denmark
Boston Scientific Corporation

Recruiting

A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM (FRONTIER)

Glioblastoma Multiforme | Recurrent Glioblastoma

United States
Boston Scientific Corporation

Recruiting

Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature (ELEGANCE)

Peripheral Vascular Diseases

United States, Australia, Taiwan, Canada, Thailand, Austria, Germany, Spain, France, China, Poland
Boston Scientific Corporation

Recruiting

Radiofrequency (RF) Ablation Prospective Outcomes Study (RAPID)

Pain, Chronic

United States, United Kingdom, Germany, Belgium, Italy, Netherlands
Boston Scientific Corporation

Recruiting

Vercise™ DBS Dystonia Prospective Study

Dystonia

Germany, United Kingdom, Italy, Belgium, Hungary, Israel, Netherlands, Poland, Russian Federation, Spain, Korea, Republic of
Boston Scientific Corporation

Recruiting

RELIEF - A Global Registry to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain (RELIEF)

Pain

United States, Spain, Germany, United Kingdom, Belgium, Colombia, Argentina, Australia, Denmark, Israel, Italy, Japan, Canada, Netherlands, Switzerland, Sweden
Boston Scientific Corporation

Active, not recruiting

POLARx™ Cardiac Cryoablation System Post Market Clinical Study (POLAR SMART) (POLAR SMART)

Paroxysmal Atrial Fibrillation

Korea, Republic of, Japan
Boston Scientific Corporation

Active, not recruiting

A RWS of the FARAPULSE in A Chinese Population With PAF

Paroxysmal Atrial Fibrillation

China
Boston Scientific Corporation

Active, not recruiting

Varithena Versus Endothermal Ablation of the Great Saphenous Vein (VERITAS) (VERITAS)

Varicose Veins

United States
Boston Scientific Corporation

Active, not recruiting

An "All-Comers" Study of the AgentTM MONORAILTM Paclitaxel-Coated PTCA Balloon Catheter Used in Real-World Clinical Practice in Chinese Patients

Chinese Patients Treated With Agent DCB

Taiwan, Hong Kong, Singapore
Boston Scientific Corporation

Active, not recruiting

CHAMPION-AF Clinical Trial (CHAMPION-AF)

Stroke | Atrial Fibrillation | Bleeding

United States, Australia, Denmark, Canada, Israel, United Kingdom, France, Belgium, Netherlands, Japan, Germany, Switzerland, Italy, Poland, Saudi Arabia, Spain
Boston Scientific Corporation

Completed

TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.

Hepatocellular Carcinoma

United States
Boston Scientific Corporation

Active, not recruiting

Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO)

Stroke

United States, Denmark, Germany, Netherlands, United Kingdom, Belgium, Canada, Czechia, Italy
Boston Scientific Corporation

Active, not recruiting

A Pilot Study to Assess WATCHMAN FLX™ Implants by Cardiac Computed Tomography, Magnetic Resonance Imaging and Transesophageal Echocardiography: WATCHMAN FLX™ CT

The Focus of the Study is to Reduce the Risk of Stroke and Life-threatening Bleeding Events in Patients With Non-valvular Atrial Fibrillation

Denmark
Boston Scientific Corporation

Active, not recruiting

Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation (OPTION)

Atrial Fibrillation

United States, Spain, Denmark, Australia, France, Germany, Italy, Poland, Belgium, Netherlands
Boston Scientific Corporation

Active, not recruiting

A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects With Persistent Atrial Fibrillation (ADVANTAGE AF)

Persistent Atrial Fibrillation

United States, Belgium, Canada, Spain
Boston Scientific Corporation

Completed

Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP (APPRAISE ATP)

Sudden Cardiac Death

United States, Spain, Korea, Republic of, United Kingdom, Canada, Japan, Austria, Italy
Boston Scientific Corporation

Active, not recruiting

A Post-Approval, Single-Arm Study of the SYNERGY Stent System in China

Cardiovascular Diseases

China
Boston Scientific Corporation

Completed

Multiple Cardiac Sensors for the Management of Heart Failure (MANAGE-HF)

Heart Failure, Congestive

United States, Germany, France
Boston Scientific Corporation

Completed

RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty (RANGER II SFA)

Atherosclerosis | Peripheral Artery Disease | Plaque, Atherosclerotic | Artery Diseases, Peripheral | Occlusive Arterial Disease

United States, Belgium, Canada, Japan, Austria, New Zealand
Boston Scientific Corporation

Completed

SpaceOAR System RWS in China

Localized T1-T2 Prostate Cancer

China
Boston Scientific Corporation

Completed

S-ICD® System Post Approval Study

Primary Prevention of Sudden Cardiac Arrest | Secondary Prevention of Sudden Cardiac Arrest

United States
Hipra Scientific, S.L.U

Completed

A Phase II Trial to Evaluate the Safety and Immunogenicity of BIMERVAX® When Coadministered With Seasonal Influenza Vaccine (SIIV) in Adults Older Than 65 Years of Age Fully Vaccinated Against COVID-19

Influenza, Human | SARS CoV 2 Infection

Spain
Boston Scientific Corporation

Active, not recruiting

Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF) (NECTAR-HF)

Heart Failure | Congestive Heart Failure

Spain, Netherlands, Germany, Italy, United Kingdom, Belgium, Czechia, France
Boston Scientific Corporation

Terminated

Tracking Renal Tumors After Cryoablation Evaluation (TRACE)

Kidney Neoplasms

United States
Boston Scientific Corporation

Completed

A Clinical Trial to Confirm Safety & Effectiveness of the SYNERGY 4.50 mm and 5.00 mm Stent for Treatment of Atherosclerotic Lesion(s)

Cardiovascular Diseases | Coronary Artery Disease | Atherosclerosis | Heart Diseases, Coronary

United States
Boston Scientific Corporation

Terminated

Step and Walking Pattern From Cardiac Monitor Study (SWAN)

Heart Failure NYHA Class II | Heart Failure NYHA Class III | Insertable Cardiac Monitor

United States
Boston Scientific Corporation

Completed

SpyGlass™ Discover Percutaneous

Pancreatic Diseases | Bile Duct Diseases | Bile Duct Obstruction

United States, Belgium, Italy, Canada, Germany, Hong Kong, India
Boston Scientific Corporation

Completed

AXIOS CHINA (E7148)

Pancreatic Pseudocyst and Walled-off Necrosis

China
Boston Scientific Corporation

Completed

Non-Complex Biliary Stones DSC vs ERC

Biliary Stones

United States, India, Thailand, Italy
Boston Scientific Corporation

Completed

ACURATE Prime XL Human Feasibility Study

Aortic Stenosis

Australia
Hipra Scientific, S.L.U

Completed

A Phase III Trial to Assess the Safety and Immunogenicity of a HIPRA's Candidate Booster Vaccination Against COVID-19.

COVID-19 | SARS-CoV-2 Acute Respiratory Disease

Spain, Italy
Boston Scientific Corporation

Completed

Precision Event Monitoring for Patients With Heart Failure Using HeartLogic (PREEMPT-HF)

Heart Failure | Cardiovascular Disease | Heart Disease | Defibrillators, Implantable | Cardiac Resynchronization Therapy | Monitoring, Physiologic

United States, Spain, United Kingdom, Netherlands, Hong Kong, Denmark, France, Ireland, Australia, Belgium, Canada, Germany, Italy
Boston Scientific Corporation

Terminated

A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma

Brain Neoplasms | Glioblastoma Multiforme

United States

Clinical Trials Sponsored by Circa Scientific

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations